The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Using MRD to Guide Therapy in AML

Harry Erba, MD, PhD
Published Online: 10:13 PM, Fri September 15, 2017

Harry Erba, MD, PhD, professor of medicine, director, University of Alabama (UAB) Hematologic Malignancy Program, UAB School of Medicine, discusses using MRD to guide therapy in acute myeloid leukemia (AML).

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.